• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Insurtech Leader Ethos Adds Industry Veteran William Wheeler to Board of Directors

    7/30/25 11:00:00 AM ET
    $EVR
    $LIFE
    $ATH
    Investment Managers
    Finance
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Get the next $EVR alert in real time by email

    AUSTIN, Texas, July 30, 2025 (GLOBE NEWSWIRE) -- Ethos, a leading life insurance technology company on a mission to democratize access to life insurance, today announced the appointment of William J. Wheeler to its Board of Directors. Mr. Wheeler, a seasoned executive with deep expertise across insurance, retirement services, and investment banking, joins Ethos' distinguished board, further strengthening Ethos' governance and strategic guidance as the company continues its rapid growth and innovation.

    Mr. Wheeler brings more than three decades of leadership experience in the financial services industry. He most recently served as Vice Chairman of Athene Holding Ltd. (NYSE:ATH), a leading retirement services company and subsidiary of Apollo Global Management, following seven years as Athene's President. Prior to Athene, Mr. Wheeler served as President of the Americas for MetLife, overseeing the company's insurance and retirement business across the United States and Latin America, and earlier served as MetLife's Chief Financial Officer. He currently serves as a director of Evercore Inc. (NYSE:EVR), chairing its Audit Committee and serving as a member of its Compensation Committee. Mr. Wheeler previously served on the boards of directors of Athora Holding Ltd. and Venerable Holdings Inc., both private insurance companies. He has also served on the American Council of Life Insurers. Mr. Wheeler holds a Bachelor of Arts degree from Wabash College, where he is the Chairman of its board of trustees, and a Master of Business Administration from Harvard Business School.

    "I'm excited to join an organization which I believe will have a significant impact on how people obtain life insurance and other financial services," said Mr. Wheeler.

    With his addition, Mr. Wheeler joins a board that, along with co-founders Peter Colis and Lingke Wang, includes Sequoia Capital's Roelof Botha, Accel's Nate Niparko, Guidewire Software's Priscilla Hung, Twilio's Khozema Shipchandler, and former PayPal executive John Kunze.

    "Bill is a seasoned operator with deep expertise in the insurance and retirement industries, and his track record of strategic leadership at some of the most respected companies in financial services will be invaluable to Ethos as we continue to expand our impact," said Peter Colis, CEO of Ethos. "We are honored to welcome him to our Board, where his perspective and guidance will help us build on our momentum and deliver even greater value to the families we serve."

    Ethos leverages proprietary technology and predictive and real-time data to remove the friction from the life insurance application process, enabling customers to apply for coverage with a fully digital application with a few health questions that provides customers with decisions in minutes, without lengthy and invasive medical exams. By streamlining the process, Ethos helps more families gain peace of mind and long-term financial stability.

    About Ethos

    Ethos is a leading life insurance technology company on a mission to protect families by democratizing access to life insurance and empowering agents at scale. With its robust three-sided technology platform, Ethos is transforming the life insurance experience for consumers, agents, and carriers alike. Ethos offers instant, accessible products and a seamless online process that requires no medical exams and just a few health questions — eliminating traditional barriers and making it easier than ever for everyone to protect their families. Each month, Ethos issues billions in coverage, redefining how life insurance is bought, sold, and underwritten.

    Learn more at ethos.com.

    Press Contact:

    Allyson Savage

    [email protected]



    Primary Logo

    Get the next $EVR alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $EVR
    $LIFE
    $ATH

    CompanyDatePrice TargetRatingAnalyst
    Evercore Inc.
    $EVR
    7/14/2025Mkt Outperform → Mkt Perform
    Citizens JMP
    Evercore Inc.
    $EVR
    6/23/2025$312.00Equal-Weight → Overweight
    Morgan Stanley
    Evercore Inc.
    $EVR
    4/8/2025$230.00Mkt Perform → Mkt Outperform
    Citizens JMP
    Evercore Inc.
    $EVR
    4/7/2025$306.00 → $173.00Overweight → Equal-Weight
    Morgan Stanley
    Evercore Inc.
    $EVR
    12/20/2024$269.00 → $339.00Mkt Perform → Outperform
    Keefe Bruyette
    Evercore Inc.
    $EVR
    9/12/2024$258.00Equal Weight
    Wells Fargo
    Evercore Inc.
    $EVR
    9/11/2024$246.00 → $276.00Neutral → Buy
    Goldman
    Evercore Inc.
    $EVR
    1/29/2024Mkt Perform
    Keefe Bruyette
    More analyst ratings

    $EVR
    $LIFE
    $ATH
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Ethos and Lifeforce Team Up to Help Policyholders Live Longer, Healthier Lives

    AUSTIN, Texas, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Ethos, a leading life insurance technology company on a mission to democratize access to life insurance, today announced a partnership with Lifeforce, the largest longevity medicine platform. Through this collaboration, Ethos policyholders will be able to gain valuable insights into their own health at affordable prices, starting with a $250 benefit to Lifeforce's Diagnostic offering, that includes at-home biomarker testing, access to board-certified longevity physicians, personalized treatment protocols, and ongoing health coaching. Together, Ethos and Lifeforce aim to help more families safeguard their future - uniting financial protection

    8/13/25 8:00:00 AM ET
    $LIFE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Insurtech Leader Ethos Adds Industry Veteran William Wheeler to Board of Directors

    AUSTIN, Texas, July 30, 2025 (GLOBE NEWSWIRE) -- Ethos, a leading life insurance technology company on a mission to democratize access to life insurance, today announced the appointment of William J. Wheeler to its Board of Directors. Mr. Wheeler, a seasoned executive with deep expertise across insurance, retirement services, and investment banking, joins Ethos' distinguished board, further strengthening Ethos' governance and strategic guidance as the company continues its rapid growth and innovation. Mr. Wheeler brings more than three decades of leadership experience in the financial services industry. He most recently served as Vice Chairman of Athene Holding Ltd. (NYSE:ATH), a leadin

    7/30/25 11:00:00 AM ET
    $EVR
    $LIFE
    $ATH
    Investment Managers
    Finance
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Evercore Reports Second Quarter 2025 Results; Quarterly Dividend of $0.84 Per Share

    Evercore Inc. (NYSE:EVR):   Second Quarter Results   Year to Date Results   U.S. GAAP   Adjusted   U.S. GAAP   Adjusted   Q2 2025 Q2 2024   Q2 2025 Q2 2024   YTD 2025 YTD 2024   YTD 2025 YTD 2024 Net Revenues ($ mm) $ 833.8   $ 689.2     $ 838.9   $ 695.3     $ 1,528.7   $ 1,270.0     $ 1,538.8   $ 1,282.6   Operating Income ($ mm) $ 150.4  

    7/30/25 6:45:00 AM ET
    $EVR
    Investment Managers
    Finance

    $EVR
    $LIFE
    $ATH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Evercore downgraded by Citizens JMP

    Citizens JMP downgraded Evercore from Mkt Outperform to Mkt Perform

    7/14/25 8:39:26 AM ET
    $EVR
    Investment Managers
    Finance

    Evercore upgraded by Morgan Stanley with a new price target

    Morgan Stanley upgraded Evercore from Equal-Weight to Overweight and set a new price target of $312.00

    6/23/25 8:01:08 AM ET
    $EVR
    Investment Managers
    Finance

    Evercore upgraded by Citizens JMP with a new price target

    Citizens JMP upgraded Evercore from Mkt Perform to Mkt Outperform and set a new price target of $230.00

    4/8/25 9:09:08 AM ET
    $EVR
    Investment Managers
    Finance

    $EVR
    $LIFE
    $ATH
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Denyes Nancy bought $9,276 worth of shares (5,000 units at $1.86), increasing direct ownership by 29% to 22,267 units (SEC Form 4)

    4 - aTYR PHARMA INC (0001339970) (Issuer)

    6/6/24 8:26:55 AM ET
    $LIFE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Coughlin Timothy bought $87,500 worth of shares (50,000 units at $1.75) (SEC Form 4)

    4 - aTYR PHARMA INC (0001339970) (Issuer)

    6/3/24 4:21:12 PM ET
    $LIFE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Broadfoot Jill Marie bought $8,950 worth of shares (5,000 units at $1.79), increasing direct ownership by 22% to 27,960 units (SEC Form 4)

    4 - aTYR PHARMA INC (0001339970) (Issuer)

    6/3/24 8:38:39 AM ET
    $LIFE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $EVR
    $LIFE
    $ATH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Lalonde Timothy Gilbert sold $2,483,764 worth of Shares of Class A common stock (8,407 units at $295.44), decreasing direct ownership by 18% to 37,463 units (SEC Form 4)

    4 - Evercore Inc. (0001360901) (Issuer)

    8/7/25 4:41:31 PM ET
    $EVR
    Investment Managers
    Finance

    General Counsel Klurfeld Jason sold $1,572,175 worth of Shares of Class A common stock (5,500 units at $285.85), decreasing direct ownership by 8% to 59,687 units (SEC Form 4)

    4 - Evercore Inc. (0001360901) (Issuer)

    8/5/25 4:57:15 PM ET
    $EVR
    Investment Managers
    Finance

    SEC Form 4 filed by Founder and Senior Chairman Altman Roger C

    4 - Evercore Inc. (0001360901) (Issuer)

    8/1/25 4:32:41 PM ET
    $EVR
    Investment Managers
    Finance

    $EVR
    $LIFE
    $ATH
    SEC Filings

    View All

    SEC Form 10-Q filed by Evercore Inc.

    10-Q - Evercore Inc. (0001360901) (Filer)

    8/7/25 4:08:19 PM ET
    $EVR
    Investment Managers
    Finance

    Evercore Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Evercore Inc. (0001360901) (Filer)

    7/30/25 6:45:17 AM ET
    $EVR
    Investment Managers
    Finance

    Evercore Inc. filed SEC Form 8-K: Regulation FD Disclosure

    8-K - Evercore Inc. (0001360901) (Filer)

    7/30/25 6:05:46 AM ET
    $EVR
    Investment Managers
    Finance

    $EVR
    $LIFE
    $ATH
    Financials

    Live finance-specific insights

    View All

    Evercore Reports Second Quarter 2025 Results; Quarterly Dividend of $0.84 Per Share

    Evercore Inc. (NYSE:EVR):   Second Quarter Results   Year to Date Results   U.S. GAAP   Adjusted   U.S. GAAP   Adjusted   Q2 2025 Q2 2024   Q2 2025 Q2 2024   YTD 2025 YTD 2024   YTD 2025 YTD 2024 Net Revenues ($ mm) $ 833.8   $ 689.2     $ 838.9   $ 695.3     $ 1,528.7   $ 1,270.0     $ 1,538.8   $ 1,282.6   Operating Income ($ mm) $ 150.4  

    7/30/25 6:45:00 AM ET
    $EVR
    Investment Managers
    Finance

    Evercore to Announce Second Quarter 2025 Financial Results and Host Conference Call on July 30, 2025

    Evercore (NYSE:EVR) will release its second quarter 2025 financial results on Wednesday, July 30, 2025 at 6:45 a.m. Eastern Time. Evercore will host a related conference call, accessible via telephone and webcast, beginning at 8:00 a.m. Eastern Time that same day. Evercore's Chairman and Chief Executive Officer, John S. Weinberg, and Chief Financial Officer, Tim LaLonde, will review the Firm's second quarter 2025 financial results. Following the review, there will be a question and answer session. This conference call is expected to last approximately one hour. Investors and analysts may participate in the live conference call by dialing (800) 274-8461 (toll-free domestic) or (203) 518-

    7/16/25 8:00:00 AM ET
    $EVR
    Investment Managers
    Finance

    Evercore Reports First Quarter 2025 Results; Increases Quarterly Dividend to $0.84 Per Share

    Evercore Inc. (NYSE:EVR):   First Quarter Results   U.S. GAAP   Adjusted   Q1 2025 Q1 2024   Q1 2025 Q1 2024 Net Revenues ($ mm) $ 694.8   $ 580.8     $ 699.9   $ 587.3   Operating Income ($ mm) $ 111.2   $ 84.1     $ 116.3   $ 90.6   Net Income Attributable to Evercore Inc. ($ mm) $ 146.2   $ 85.7     $ 154.8   $ 92.9   Diluted Earnings Per Share $ 3.48   $ 2.09     $ 3.49   $ 2.13   Compensation Ratio   66.2 %   66.8 %     65.7 %   66.0

    4/30/25 6:45:00 AM ET
    $EVR
    Investment Managers
    Finance

    $EVR
    $LIFE
    $ATH
    Leadership Updates

    Live Leadership Updates

    View All

    Insurtech Leader Ethos Adds Industry Veteran William Wheeler to Board of Directors

    AUSTIN, Texas, July 30, 2025 (GLOBE NEWSWIRE) -- Ethos, a leading life insurance technology company on a mission to democratize access to life insurance, today announced the appointment of William J. Wheeler to its Board of Directors. Mr. Wheeler, a seasoned executive with deep expertise across insurance, retirement services, and investment banking, joins Ethos' distinguished board, further strengthening Ethos' governance and strategic guidance as the company continues its rapid growth and innovation. Mr. Wheeler brings more than three decades of leadership experience in the financial services industry. He most recently served as Vice Chairman of Athene Holding Ltd. (NYSE:ATH), a leadin

    7/30/25 11:00:00 AM ET
    $EVR
    $LIFE
    $ATH
    Investment Managers
    Finance
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Luigi de Vecchi to Join Evercore's European Advisory Practice as Firm Continues to Build in Europe

    Evercore (NYSE:EVR) announced today that Luigi de Vecchi will be joining the firm in September 2025 as senior managing director and chairman of its continental European advisory business. He will be based in Milan, Italy, where Evercore is in the process of opening an office. Mr. de Vecchi brings over 35 years of investment banking experience to Evercore and has advised on some of Europe and Italy's largest and most high-profile transactions. At Evercore, he will spearhead the buildout of the firm's presence in Italy, and Europe more broadly. He will work in close partnership with Evercore's existing team in Paris, focusing on the firm's large European and global strategic clients. "I a

    7/25/25 3:00:00 AM ET
    $EVR
    Investment Managers
    Finance

    Jon Josephs Joins Evercore as Senior Managing Director in the Industrials Investment Banking Group

    Evercore (NYSE:EVR) announced today that Jon Josephs has joined the firm as a senior managing director in the Industrials Investment Banking group, focused on capital goods and large-cap diversified companies, based in New York. "We look forward to welcoming Jon to the firm," said Jason Sobol, co-head of U.S. Investment Banking. "His expertise and deep-rooted relationships across the Industrials sector will reinforce our ongoing commitment to delivering exceptional outcomes for our clients." Mr. Josephs said, "I am delighted and honored to join the Evercore Industrials team. Evercore's comprehensive approach to independent strategic advisory and exceptional execution capabilities offers

    7/7/25 8:00:00 AM ET
    $EVR
    Investment Managers
    Finance

    $EVR
    $LIFE
    $ATH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Evercore Inc.

    SC 13G/A - Evercore Inc. (0001360901) (Subject)

    10/4/24 2:32:45 PM ET
    $EVR
    Investment Managers
    Finance

    SEC Form SC 13G/A filed by aTyr Pharma Inc. (Amendment)

    SC 13G/A - aTYR PHARMA INC (0001339970) (Subject)

    2/14/24 1:43:55 PM ET
    $LIFE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form SC 13G/A filed by Evercore Inc. (Amendment)

    SC 13G/A - Evercore Inc. (0001360901) (Subject)

    2/13/24 5:04:33 PM ET
    $EVR
    Investment Managers
    Finance